Sponsors

Commerce and COVID-19: a need for reconfiguration and transformation

The in vitro diagnostics industry has been at the forefront of the fight against SARS-CoV-2. Here, Mark Reed provides a commercial perspective and overview of the unprecedented times experienced over the past 12 months.

Looking back at 2020, I am quite sure that there isn’t a diagnostic manufacturing or distribution company in the UK, or even the world, that hasn’t been affected in some way by the SARS-CoV-2 pandemic, be that professionally or personally.

            As coronavirus continues to spread, and mutate, so testing methods have developed to detect the virus more effectively. Testing has always been integral to diagnosis, understanding its spread, and taking preventive measures to protect populations. The more rapid and reliable the test, the quicker there can be a diagnosis.

A brief timeline review

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025